Abstract CT154: An ascending single and multiple dose study of the safety, tolerability, pharmacokinetics and antitumor activity of once-daily oral treatment with EO1001, a novel irreversible pan-ErbB inhibitor with promising brain penetration, in patients with advanced cancer
Bacha, Jeffrey A., Brown, Dennis, Kanekal, Sarath, Nisbet, Ian, Sankar, Neil, Shen, Wang, Wheeler, Helen, Skoff, Kathy, Wang, Zhen Zhong
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article
CTNI-08. A PHASE 1–2 CLINICAL TRIAL OF EO1001, A NOVEL IRREVERSIBLE PAN-ErbB INHIBITOR WITH PROMISING BRAIN PENETRATION
Wheeler, Helen, Bacha, Jeffrey, Brown, Dennis, Kanekal, Sarath, Sankar, Neil, Nisbet, Ian, Skoff, Kathy, Shen, Wang, ZhenZhong, Wang, Pedersen, Harry
Published in Neuro-oncology (Charlottesville, Va.) (09.11.2020)
Published in Neuro-oncology (Charlottesville, Va.) (09.11.2020)
Get full text
Journal Article
CTNI-01. A PHASE 1-2 CLINICAL TRIAL OF EO1001 (APL-122), A NOVEL IRREVERSIBLE PAN-ERBB INHIBITOR WITH PROMISING BRAIN PENETRATION
Frentzas, Sophia, Richardson, Gary, Bacha, Jeffrey, Kanekal, Sarath, Sankar, Neil, Shen, Wang, Redkar, Sanjeev, Lai, Chinglin, Yu, Peony, Nisbet, Ian, Skoff, Kathy, Wheeler, Helen, Pedersen, Harry, Zhong, Wang Zhen, Brown, Dennis
Published in Neuro-oncology (Charlottesville, Va.) (12.11.2021)
Published in Neuro-oncology (Charlottesville, Va.) (12.11.2021)
Get full text
Journal Article
70. A PHASE 1–2 CLINICAL TRIAL OF EO1001, A NOVEL IRREVERSIBLE pan-ErbB INHIBITOR WITH PROMISING BRAIN PENETRATION
Wheeler, Helen, Bacha, Jeffrey, Kanekal, Sarath, Pedersen, Harry, Sankar, Neil, Wang, Shen, Nesbit, Ian, Skoff, Kathy, Brown, Dennis
Published in Neuro-oncology advances (04.08.2020)
Published in Neuro-oncology advances (04.08.2020)
Get full text
Journal Article
Efficacy and safety of oral methazolamide in patients with type 2 diabetes: a 24-week, placebo-controlled, double-blind study
Simpson, Richard W, Nicholson, Geoffrey C, Proietto, Joseph, Sarah, Alana, Sanders, Kerrie M, Phillips, Gabrielle, Chambers, Jo, MacGinley, Rob, Orford, Neil, Walder, Ken, Krippner, Guy, Skoff, Kathy, Wacher, Vincent J
Published in Diabetes care (01.11.2014)
Published in Diabetes care (01.11.2014)
Get full text
Journal Article
TRLS-06. A Phase 1–2 clinical trial of EO1001 (APL-122), a novel irreversible pan-ErbB inhibitor with promising brain penetration
Frentzas, Sophia, Richardson, Gary, Bacha, Jeffrey, Kanekal, Sarath, Sankar, Neil, Shen, Wang, Redkar, Sanjeev, Lai, Chinglin, Yu, Peony, Nisbet, Ian, Skoff, Kathy, Wheeler, Helen, Pedersen, Harry, Zhong, Wang Zhen, Brown, Dennis
Published in Neuro-oncology advances (09.08.2021)
Published in Neuro-oncology advances (09.08.2021)
Get full text
Journal Article
Selection of an adjuvant for vaccination with the malaria antigen, MSA-2
Pye, David, Vandenberg, Kirsten L., Dyer, Shanny L., Irving, David O., Goss, Neil H., Woodrow, Graeme C., Saul, Allan, Alving, Carl R., Richards, Roberta L., Ballou, W.Ripley, Wu, Ming-Jie, Skoff, Kathy, Anders, Robin F.
Published in Vaccine (01.06.1997)
Published in Vaccine (01.06.1997)
Get full text
Journal Article